Works matching DE "ETRAVIRINE (Drug)"

Results: 99
    1
    2
    3
    4
    5

    Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study

    Published in:
    Pharmacotherapy, 2019, v. 39, n. 4, p. 514, doi. 10.1002/phar.2242
    By:
    • Lê, Minh Patrick;
    • Valantin, Marc‐Antoine;
    • Assoumou, Lambert;
    • Soulie, Cathia;
    • Le Mestre, Soizic;
    • Weiss, Laurence;
    • Yazdanpanah, Yazdan;
    • Molina, Jean‐Michel;
    • Bouchaud, Olivier;
    • Raffi, François;
    • Reynes, Jacques;
    • Calvez, Vincent;
    • Marcelin, Anne‐Geneviève;
    • Costagliola, Dominique;
    • Katlama, Christine;
    • Peytavin, Gilles;
    • Duvivier, Claudine;
    • Goujard, Cécile;
    • Jeantils, Vincent;
    • Salmon, Dominique
    Publication type:
    Article
    6

    Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavir.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 1, p. 105, doi. 10.1007/s10156-010-0082-4
    By:
    • Nakamura, Hitomi;
    • Miyazaki, Naoko;
    • Hosoya, Noriaki;
    • Koga, Michiko;
    • Odawara, Takashi;
    • Kikuchi, Tadashi;
    • Koibuchi, Tomohiko;
    • Kawana-Tachikawa, Ai;
    • Fujii, Takeshi;
    • Miura, Toshiyuki;
    • Iwamoto, Aikichi
    Publication type:
    Article
    7
    8
    9
    10

    HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2084, doi. 10.1093/jac/dkv049
    By:
    • Frange, Pierre;
    • Assoumou, Lambert;
    • Descamps, Diane;
    • Chéret, Antoine;
    • Goujard, Cécile;
    • Tran, Laurent;
    • Gousset, Marine;
    • Avettand-Fenoël, Veronique;
    • Bocket, Laurence;
    • Fafi-Kremer, Samira;
    • Guinard, Jerome;
    • Morand-Joubert, Laurence;
    • Nicot, Florence;
    • Plantier, Jean-Christophe;
    • Rogez, Sylvie;
    • Wirden, Marc;
    • Rouzioux, Christine;
    • Meyer, Laurence;
    • Chaix, Marie-Laure
    Publication type:
    Article
    11
    12
    13
    14

    Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 12, p. 2882, doi. 10.1093/jac/dkt272
    By:
    • Todesco, Eve;
    • Sayon, Sophie;
    • Fourati, Slim;
    • Tubiana, Roland;
    • Simon, Anne;
    • Ktorza, Nadine;
    • Schneider, Luminita;
    • Peytavin, Gilles;
    • Malet, Isabelle;
    • Van den Eede, Peter;
    • Katlama, Christine;
    • Calvez, Vincent;
    • Marcelin, Anne-Genevieve;
    • Wirden, Marc
    Publication type:
    Article
    15
    16
    17

    Etravirine in CSF is highly protein bound.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 5, p. 1161
    By:
    • Nguyen, Anh;
    • Rossi, Steven;
    • Croteau, David;
    • Best, Brookie M.;
    • Clifford, David;
    • Collier, Ann C.;
    • Gelman, Benjamin;
    • Marra, Christina;
    • McArthur, Justin;
    • McCutchan, J. Allen;
    • Morgello, Susan;
    • Simpson, David;
    • Ellis, Ronald J.;
    • Grant, Igor;
    • Capparelli, Edmund;
    • Letendre, Scott
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).

    Published in:
    HIV Medicine, 2023, v. 24, n. 11, p. 1150, doi. 10.1111/hiv.13525
    By:
    • Rancan, Ilaria;
    • Cassol, Chiara;
    • Graziani, Lucia;
    • Tilli, Marta;
    • Malcontenti, Costanza;
    • Russo, Chiara;
    • Bottanelli, Martina;
    • Bracchitta, Fiorenza;
    • Papaioannu, Rebecka;
    • Labate, Laura;
    • Mora, Sara;
    • Bezenchek, Antonia;
    • Shallvari, Adrian;
    • Di Biagio, Antonio;
    • Rossetti, Barbara
    Publication type:
    Article
    26
    27
    28

    Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.

    Published in:
    HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218
    By:
    • Vingerhoets, J;
    • Calvez, V;
    • Flandre, P;
    • Marcelin, A‐G;
    • Ceccherini‐Silberstein, F;
    • Perno, C‐F;
    • Mercedes Santoro, M;
    • Bateson, R;
    • Nelson, M;
    • Cozzi‐Lepri, A;
    • Grarup, J;
    • Lundgren, J;
    • Incardona, F;
    • Kaiser, R;
    • Sonnerborg, A;
    • Clotet, B;
    • Paredes, R;
    • Günthard, HF;
    • Ledergerber, B;
    • Hoogstoel, A
    Publication type:
    Article
    29
    30
    31
    32

    Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest

    Published in:
    HIV Medicine, 2012, v. 13, n. 7, p. 427, doi. 10.1111/j.1468-1293.2012.00994.x
    By:
    • Girard, P-M;
    • Campbell, TB;
    • Grinsztejn, B;
    • Hartikainen, J;
    • Rachline, A;
    • Nijs, S;
    • Witek, J
    Publication type:
    Article
    33

    Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.

    Published in:
    Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00239
    By:
    • Mulligan, Nikki;
    • Schalkwijk, Stein;
    • Best, Brookie M.;
    • Colbers, Angela;
    • Wang, Jiajia;
    • Capparelli, Edmund V.;
    • Moltó, José;
    • Stek, Alice M.;
    • Taylor, Graham;
    • Smith, Elizabeth;
    • Tenorio, Carmen Hidalgo;
    • Chakhtoura, Nahida;
    • van Kasteren, Marjo;
    • Fletcher, Courtney V.;
    • Mirochnick, Mark;
    • Burger, David
    Publication type:
    Article
    34
    35
    36

    Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

    Published in:
    International Journal of STD & AIDS, 2012, v. 23, n. 7, p. 459, doi. 10.1258/ijsa.2012.011391
    By:
    • Bucciardini, R.;
    • D'Ettorre, G.;
    • Baroncelli, S.;
    • Ceccarelli, G.;
    • Parruti, G.;
    • Weimer, L. E.;
    • Fragola, V.;
    • Galluzzo, C. M.;
    • Pirillo, M. F.;
    • Lucattini, S.;
    • Bellagamba, R.;
    • Francisci, D.;
    • Ladisa, N.;
    • Antoni, A. Degli;
    • Guaraldi, G.;
    • Manconi, P. E.;
    • Vullo, V.;
    • Preziosi, R.;
    • Cirioni, O.;
    • Verucchi, G.
    Publication type:
    Article
    37
    38

    Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population.

    Published in:
    PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097262
    By:
    • López-Cortés, Luis F.;
    • Viciana, Pompeyo;
    • Girón-González, José A.;
    • Romero-Palacios, Alberto;
    • Márquez-Solero, Manuel;
    • Martinez-Perez, Maria A.;
    • López-Ruz, Miguel A.;
    • de la Torre-Lima, Javier;
    • Téllez-Pérez, Francisco;
    • Delgado-Fernández, Marcial;
    • Garcia-Lázaro, Milagros;
    • Lozano, Fernando;
    • Mohamed-Balghata, Mohamed O.
    Publication type:
    Article
    39
    40
    41

    Product Update.

    Published in:
    Canadian Pharmacists Journal, 2013, v. 146, n. 1, p. 18, doi. 10.1177/1715163512473724
    By:
    • Bhalla, Alka
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50